Loading
Latest filing published 24 Oct 2022 for BioPharma Credit PLC, €48k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Rolf Soderstrom discloses dealings in BioPharma Credit PLC to RNS (LSE). The record holds 2 filings, for trades running from 30 September 2020 to 24 October 2022.
Every open-market trade on record is a purchase: 2 purchases worth €91k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2022, the count stands at 1 purchase and no sales.
The newest entry dates from 24 October 2022: an open-market purchase of €48k, in BioPharma Credit PLC. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 1 declaration